We’re a B2B digital healthcare company employing cognitive Artificial Intelligence (AI) and enterprise-level software to expand our technology and extensive behavioral research on the effect of subconscious remodeling upon remission of adiposity-based chronic disease. Type 2 diabetes (T2DM) is the low-hanging fruit.
Our mission is to help enterprises reduce healthcare costs and improve quality of life, while earning an attractive return for our investors.
Daily Therapy©: 12-weeks automated, self-learning, behavioral, lifestyle, and nutrition podcasts and interactive quizzes start the member’s cognitive AI experience and compliance.
MCI Health® Networks: AI-based, single-click, referral -to- results ecosystem and subconscious remodeling for population health.
Health Factory®: ketogenic protein meal and vitamin distributorship.
Company Information: Dashboards
- T2DM Remission Metrics
- Population Health Remission
- Subconscious Recalibration
- Certified Cost Savings
- Compliance %
- Analytics
- Satisfaction %
Validated cost saving, improved outcomes, satisfaction, and population health metrics are the basis for our growth strategy. Fortune-level enterprise member companies belonging to regional healthcare consortiums and third-party administrators (TPA’s) are actively looking for these results.
Samuel is a graduate of Chicago Medical School and a retired heart surgeon. He was an international Principal Investigator for FDA Phase III Trials for ATS Medical, Inc. (ATSI-Nasdaq). He founded University Medical Clinics Inc., a network of primary care clinics contracting with Medicare and HMOs. Samuel co-authored the company’s Daily Therapy© software and was the Investigator for the company’s virtual Phase I/II T2DM remission trials.
Jason is a US Navy veteran and liaison with the web technology and operations teams. He was a network development executive in the HMO industry and formerly COO of University Medical Clinics, Inc. He co-authored the company’s Daily Therapy© software and AI-based personal algorithms. Jason and Samuel co-designed the company’s patent-pending ecosystem.
Nick is acting COO and formerly Southeast US and Northern Caribbean Operations Director for St. Jude Medical and Medtronic. He was charged with contracting and purchasing with some of the country’s largest hospital systems. He is co-founder of Chelexa BioSciences, a patented technology to prevent MRSA, licensed to Hoth Therapeutics (NASDAQ). Nick is a Vietnam veteran serving as a Captain in the US Marine Corp.
John Hablik is an experienced and highly effective entrepreneur, having graduated University Colorado in operations management. In 2017 he co-founded and successfully operates the then largest medical marijuana clinic in South Florida. He has since separately acquired a major primary care medical clinic.
February 3, 2021
A teaming agreement and BAA’s were executed with an internal medicine clinical partner for a 1-year T2DM remission prototype of 30 obese, costly T2DM seniors for certified cost savings and outcomes. Our partner participates in a shared savings contract with a 78,000 person Medicare contracted, accountable care organization (ACO) in Palm Beach County, Florida. Member … Continued
January 1, 2021
Leveraging IBM Watson Technology to expand our Phase III clinical research for subconscious remodeling, actual cost savings, improved compliance, increased remission, and scale. Our virtual, end-end ecosystem is ready to launch final technology and enrollment steps.